SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-000331
Filing Date
2023-01-03
Accepted
2023-01-03 09:22:29
Documents
1
Effectiveness Date
2023-01-03

Document Format Files

Seq Description Document Type Size
1 S-8 POS (REG #: 333-234416) d418155ds8pos.htm S-8 POS 22062
  Complete submission text file 0001193125-23-000331.txt   23105
Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-234416 | Film No.: 23500524
SIC: 2836 Biological Products, (No Diagnostic Substances)